Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.830
+0.040 (2.23%)
At close: Dec 20, 2024, 4:00 PM
1.880
+0.050 (2.72%)
After-hours: Dec 20, 2024, 7:03 PM EST
Akebia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 399 | 234 | 106 | 395 | 405 | 752 | |
Market Cap Growth | 29.30% | 120.08% | -73.16% | -2.30% | -46.16% | 16.23% | |
Enterprise Value | 468 | 301 | 121 | 363 | 241 | 640 | |
Last Close Price | 1.83 | 1.24 | 0.58 | 2.26 | 2.80 | 6.32 | |
PS Ratio | 2.19 | 1.20 | 0.36 | 1.87 | 1.37 | 2.24 | |
PB Ratio | -5.51 | -7.64 | 20.30 | 5.34 | 1.63 | 1.90 | |
P/TBV Ratio | - | - | - | - | 8.36 | 15.50 | |
EV/Sales Ratio | 2.76 | 1.55 | 0.41 | 1.71 | 0.82 | 1.91 | |
EV/EBITDA Ratio | 106.22 | - | 39.44 | - | - | - | |
Debt / Equity Ratio | -2.05 | -3.41 | 30.07 | 2.56 | 0.51 | 0.27 | |
Debt / EBITDA Ratio | 10.97 | - | 18.82 | - | - | - | |
Asset Turnover | 0.77 | 0.65 | 0.66 | 0.36 | 0.42 | 0.38 | |
Inventory Turnover | 1.38 | 2.13 | 0.77 | 1.67 | 0.72 | 0.91 | |
Quick Ratio | 1.01 | 0.82 | 1.01 | 0.79 | 1.59 | 0.90 | |
Current Ratio | 1.52 | 1.18 | 1.43 | 1.04 | 1.98 | 1.49 | |
Return on Equity (ROE) | - | - | -237.83% | -175.37% | -119.82% | -54.27% | |
Return on Assets (ROA) | -9.37% | -9.30% | -4.89% | -24.27% | -15.41% | -19.74% | |
Return on Capital (ROIC) | -32.60% | -23.56% | -10.17% | -44.71% | -24.88% | -30.24% | |
Earnings Yield | -11.52% | -22.23% | -88.77% | -71.32% | -95.09% | -37.20% | |
FCF Yield | -9.65% | -10.01% | -69.03% | -63.99% | -27.35% | -35.13% | |
Buyback Yield / Dilution | -9.55% | -2.56% | -10.14% | -19.85% | -16.95% | -104.00% | |
Total Shareholder Return | -9.55% | -2.56% | -10.14% | -19.85% | -16.95% | -104.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.